Attached files

file filename
8-K - FORM 8-K - PENFORD CORPd821448d8k.htm

Exhibit 99.1

 

Contacts:    Ellen G. Grinde
   Director, Investor Relations and Communications
   (630) 590-0707
   egrinde@penx.com

PENFORD REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 FINANCIALRESULTS

 

    Fourth quarter diluted EPS improved to $0.23 from a loss in last year’s fourth quarter.

 

    Full year diluted EPS increased to $0.60 from $0.32 in fiscal year 2013.

 

    The Company’s Specialty Food and Bio-Products businesses each grew by double digits in the fourth quarter and fiscal year.

 

    On October 14, 2014, the Company entered into a merger agreement with Ingredion Incorporated.

CENTENNIAL, CO, November 13, 2014 – Penford Corporation (Nasdaq: PENX), a leader in ingredient systems for food and industrial markets, today reported fourth quarter and fiscal year 2014 results.

Fiscal 2014 net income improved 94% over 2013 to $7.8 million. Diluted earnings per share for the fiscal year ended August 31, 2014, increased to $0.60 from $0.32 a year ago. Gross margin expanded by over 20% to $54.3 million for the year, benefiting from higher profitability in both divisions. Consolidated sales for the year were $443.9 million compared with $467.3 million in the last fiscal year, primarily reflecting lower corn prices that were passed through to customers and reduced industrial starch and by-product revenues.

Fourth quarter net income increased to $3.0 million, or $0.23 per diluted share, from a loss in last year’s comparable quarter. Gross margin in the fourth quarter rose to $16.6 million, more than double last year’s result. Quarterly consolidated sales were $109.1 million compared to $117.4 million in fourth quarter 2013.

Penford Corporation - Financial Highlights:

 

     3 Months Ended August 31     Year Ended August 31  
(In thousands)    2014      2013     Change     2014      2013      Change  

Food Ingredients:

               

Sales

   $ 32,343       $ 28,441        13.7   $ 126,590       $ 111,234         13.8

Gross Margin

     9,982         9,111        9.6     37,641         34,399         9.4

EBITDA*

     6,589         6,678        (1.3 )%      26,602         25,326         5.0

Industrial Ingredients:

               

Sales

   $ 76,744       $ 88,986        (13.8 )%    $ 317,283       $ 356,016         (10.9 )% 

Gross Margin

     6,580         (1,515     N/A        16,666         10,648         56.5

EBITDA*

     4,121         (2,114     N/A        12,838         7,721         66.3

Consolidated:

               

Sales

   $ 109,086       $ 117,427        (7.1 )%    $ 443,873       $ 467,250         (5.0 %) 

Gross Margin

     16,561         7,597        118.0     54,307         45,047         20.6

EBITDA*

     7,692         1,784        331.2     27,871         22,805         22.2

Net income(loss)

     2,954         (949     N/A        7,753         4,007         93.5

 

* See the Reconciliation Table below.

 

1


Highlights for the quarter and the year are as follows:

Food Ingredients Division

 

    Food Ingredients revenue increased 14% to a record $126.6 million for the year on strong growth in several specialty starch segments and the acquisition of Gum Technology.

 

    Fourth quarter revenue also rose by 14% to $32.3 million, and gross margin improved 10% on double-digit increases in several product segments. Operating expenses increased by 50% in the quarter, primarily due to the Gum Technology acquisition, additional commercial resources and some one-time costs associated with expanded R&D facilities.

Industrial Ingredients Division

 

    Fiscal year revenue declined by 11% to $317.3 million largely due to the declining market price of corn which reduced industrial starch pass-through by 33% and by-product revenues by 24%. Full year gross margin expanded 56% to $16.7 million on improved ethanol market dynamics, growth of our specialty bio-products, and lower cost of physical corn. In the 2014 third quarter, the Company announced an adjustment to the estimated useful lives of certain assets. This change reduced depreciation expenses by $1.4 million for the year.

 

    In the fourth quarter, gross margin improved by $8.1 million to $6.6 million from a loss in last year’s quarter. Revenue from specialty bio-products grew by double-digits on multiple new customer gains.

Credit Facility

 

    On August 1, 2014, Penford closed on new $170 million credit facilities, replacing a prior revolving credit agreement.

Merger Details

 

    The Company entered into a merger agreement with Ingredion Incorporated on October 14, 2014.

 

    When the transaction closes, Ingredion will acquire all outstanding shares of Penford for $19.00 in cash per share.

 

    The transaction is subject to Penford shareholder and regulatory approvals as well as other customary closing conditions.

As a result of the announcement of the definitive merger agreement with Ingredion Incorporated, Penford Corporation will not host a conference call to discuss the results of the fourth quarter and full fiscal year 2014.

About Penford Corporation

Penford Corporation develops, manufactures and markets specialty ingredient systems for a variety of food and industrial products. Penford operates six manufacturing facilities and three research and development centers in the United States.

The statements contained in this release that are not historical facts are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as “believes,” “may,” “will,” “looks,” “should,” “could,” “anticipates,” “expects,” or comparable terminology or by discussions of strategies or trends. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly affect expected results. Actual future results could differ materially from those described in such forward-looking statements, and the Company does not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that could cause actual results to differ materially are the risks and uncertainties discussed in this release and those described from time to time in other filings with the Securities and Exchange Commission which include, but are not limited to: competition; the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors; product development risk; changes in corn and other raw material prices and availability; the Company’s inability to comply with the terms of instruments governing the Company’s debt; changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company’s products, including changes in government rules or incentives affecting ethanol consumption, unfavorable shifts in product mix; unanticipated costs, expenses or third party claims; impairment of the Company’s long-lived assets that could result in a noncash charge to reported earnings; interest rate, chemical and energy cost volatility; changes in returns on pension plan assets and/or assumptions used for determining employee benefit expense and obligations; unforeseen developments in the industries in which Penford operates; and other factors described in the “Risk Factors” section in reports filed with the Securities and Exchange Commission.

###

TABLES TO FOLLOW

 

2


Penford Corporation

Financial Highlights

 

     Three months ended August 31     Year ended August 31  
(In thousands, except per share data)    2014     2013     2014     2013  
     (unaudited)        

Consolidated Results

  

Sales

   $ 109,086      $ 117,427      $ 443,873      $ 467,250   

Income (loss) from operations

   $ 5,814      $ (1,421   $ 15,291      $ 9,404   

Net income (loss)

   $ 2,954      $ (949   $ 7,753      $ 4,007   

Earnings (loss) per share, diluted

   $ 0.23      $ (0.08   $ 0.60      $ 0.32   

Cash Flows

  

Cash flow provided by (used in) operations:

        

Operating activities

   $ 6,717      $ 10,069      $ 18,054      $ 24,649   

Investing activities

     (4,909     (5,861     (22,325     (12,062

Financing activities

     (2,002     (4,244     4,239        (12,520
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cash provided by (used in ) operations

   $ (194   $ (36   $ (32   $ 67   

 

Balance Sheets  
     August 31,      August 31,  
     2014      2013  

Current assets

   $ 98,444       $ 90,114   

Property, plant and equipment, net

     114,804         112,141   

Other assets

     25,942         22,363   
  

 

 

    

 

 

 

Total assets

     239,190         224,618   
  

 

 

    

 

 

 

Current liabilities

     39,015         35,640   

Long-term debt

     76,665         72,739   

Other liabilities

     31,377         33,346   

Shareholders’ equity

     92,133         82,893   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 239,190       $ 224,618   
  

 

 

    

 

 

 

 

3


Penford Corporation

Consolidated Statements of Operations

 

     Three months ended August 31,     Year ended August 31,  
    

(Unaudited)

       

(In thousands, except per share data)

   2014     2013     2014      2013  

Sales

   $ 109,086      $ 117,427      $ 443,873       $ 467,250   

Cost of sales

     92,525        109,830        389,566         422,203   
  

 

 

   

 

 

   

 

 

    

 

 

 

Gross margin

     16,561        7,597        54,307         45,047   

Operating expenses

     9,088        7,504        33,407         29,773   

Research and development expenses

     1,659        1,514        5,609         5,870   
  

 

 

   

 

 

   

 

 

    

 

 

 

Income (loss) from operations

     5,814        (1,421     15,291         9,404   

Interest expense

     1,019        927        3,583         3,989   

Other non-operating income (expense), net

     (262     7        766         75   
  

 

 

   

 

 

   

 

 

    

 

 

 

Income (loss) before income taxes

     4,533        (2,341     12,474         5,490   

Income tax expense (benefit)

     1,579        (1,392     4,721         1,483   
  

 

 

   

 

 

   

 

 

    

 

 

 

Net income (loss)

   $ 2,954      $ (949   $ 7,753       $ 4,007   
  

 

 

   

 

 

   

 

 

    

 

 

 

Weighted average common shares and equivalents outstanding, diluted

     12,895        12,431        12,858         12,618   

Earnings (loss) per common share, diluted

   $ 0.23      $ (0.08   $ 0.60       $ 0.32   

 

4


Penford Corporation

Reconciliation of Non-GAAP Measure

To supplement the segment and consolidated financial results prepared in accordance with generally accepted accounting principles (“GAAP”), the Company utilizes a non-GAAP financial measure-net income (loss) before interest, taxes, depreciation and amortization expense (“EBITDA”). The Company uses EBITDA to evaluate performance and establish goals. The Company believes that this measure is valuable to investors in assessing the Company’s operating results when viewed in conjunction with GAAP results. This non-GAAP measure is not a substitute for, or an alternative to, the corresponding measure calculated in accordance with GAAP.

 

Reconciliation of non-GAAP EBITDA to GAAP Operating Income (Loss)

 
(In thousands)    Three months ended August 31, 2014     Year ended August 31, 2014  
     Food
Ingredients
    Industrial
Ingredients
     Consolidated     Food
Ingredients
    Industrial
Ingredients
     Consolidated  

Operating income

   $ 5,996      $ 2,659       $ 5,814      $ 24,345      $ 2,587       $ 15,291   

Depreciation and amortization

     594        1,458         2,140        2,260        9,219         11,814   

Iowa loan forgiveness

     —          —           —          —          1,000         1,000   

Loss on early extinguishment of debt

     —          —           (265     —          —           (265

Other non-operating income (loss)

     (1     4         3        (3     32         31   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

EBITDA

   $ 6,589      $ 4,121       $ 7,692      $ 26,602      $ 12,838       $ 27,871   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

 

     Three months ended August 31, 2013     Year ended August 31, 2013  
     Food
Ingredients
     Industrial
Ingredients
    Consolidated     Food
Ingredients
     Industrial
Ingredients
    Consolidated  

Operating income (loss)

   $ 6,168       $ (4,738   $ (1,421   $ 23,265       $ (3,238   $ 9,404   

Depreciation and amortization

     510         2,607        3,198        2,061         10,933        13,326   

Other non-operating income

     —           17        7        —           26        75   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

EBITDA

   $ 6,678       $ (2,114   $ 1,784      $ 25,326       $ 7,721      $ 22,805   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

 

5